Cargando…

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review

Detalles Bibliográficos
Autores principales:	Schmidt, Stefanie, Kunath, Frank, Coles, Bernadette, Draeger, Desiree Louise, Krabbe, Laura-Maria, Dersch, Rick, Kilian, Samuel, Jensen, Katrin, Dahm, Philipp, Meerpohl, Joerg J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2020
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329645/ https://www.ncbi.nlm.nih.gov/pubmed/32665991 http://dx.doi.org/10.4111/icu.2020.61.4.349

Ejemplares similares

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
por: Han, Mi Ah, et al.
Publicado: (2021)

Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
por: Chowdhury, Anadi Roy, et al.
Publicado: (2013)

Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015)

Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy
por: Minakata, Tomokazu, et al.
Publicado: (2020)

Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
por: Taniguchi, Yoshinori, et al.
Publicado: (2022)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy
por: Obaid, Sami, et al.
Publicado: (2011)

Morbilliform eruption in a patient receiving intravesical Bacilli Calmette-Guérin
por: Reid, Holly, et al.
Publicado: (2014)

Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy
por: Klebanov, Nikolai, et al.
Publicado: (2018)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
por: Ghafouri, Sayed Ab. Reshad, et al.
Publicado: (2018)

Tuberculosis epididymo-orchitis following intravesical bacillus Calmette-Guérin immunotherapy
por: Rezvani, Sean, et al.
Publicado: (2019)

Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy
por: Kaburaki, Kyohei, et al.
Publicado: (2017)

Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
por: Miyazaki, Masashi, et al.
Publicado: (2016)

Tuberculous prostatic abscess following intravesical bacillus Calmette-Guérin immunotherapy
por: Wang, Bin, et al.
Publicado: (2019)

Comparison of intravesical bacillus Calmette-Guerin and mitomycin C administration for non-muscle invasive bladder cancer: A meta-analysis and systematic review
por: JIANG, SHANG-JUN, et al.
Publicado: (2016)

Weekly intravesical bacillus Calmette-Guerin (BCG) alternating with epirubicin in Ta and T1 urothelial bladder cancer: An approach to decrease BCG toxicity
por: Ali-El-Dein, Bedeir, et al.
Publicado: (2013)

Pityriasis Rosea-Like Rash Secondary to Intravesical Bacillus Calmette-Guerin Immunotherapy
por: Oh, Chee Won, et al.
Publicado: (2012)

Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin
por: Samannodi, Mohammed, et al.
Publicado: (2018)

Evaluation of the Dwell-Time and Dose Difference in Intravesical Bacillus Calmette-Guèrin Therapy
por: Nagai, Takashi, et al.
Publicado: (2019)

A severe complication of intravesical bacillus Calmette-Guerin: An effect of different strains
por: Low, Li Sian, et al.
Publicado: (2021)

Spinal Tuberculosis Secondary to Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer
por: Yergin, Celeste G, et al.
Publicado: (2021)

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
por: Huang, Di, et al.
Publicado: (2019)

Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guérin for Ta and T1 bladder cancer: a systematic review and meta-analysis
por: Lu, Jun-Lin, et al.
Publicado: (2021)

Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy
por: Aslan, Guven, et al.
Publicado: (2013)

Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
por: Madbouly, Khaled
Publicado: (2013)

Tuberculous Prostatic Abscess with Prostatorectal Fistula after Intravesical Bacillus Calmette-Guérin Immunotherapy
por: Eom, Jeong Ho, et al.
Publicado: (2016)

Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer
por: Liu, Yuqing, et al.
Publicado: (2019)

Henoch Schönlein Purpura Nephritis Associated with Intravesical Bacillus Calmette-Guerin (BCG) Therapy
por: Tsukada, Hiroyuki, et al.
Publicado: (2017)

Hepatic Injury without Granulomatous Formation Associated with Intravesical Bacillus Calmette-Guérin Therapy
por: Okano, Hiroshi, et al.
Publicado: (2019)

Mycobacterium Bovis Spondylodiscitis: A Rare Complication of Intravesical Bacillus Calmette-Guérin Therapy
por: Quatannens, Frédéric, et al.
Publicado: (2022)

Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report
por: Kawai, Akihito, et al.
Publicado: (2022)

Intravesical bacillus Calmette–Guérin-induced myopathy presenting as rhabdomyolysis: a case report
por: Lee, Chae Hun, et al.
Publicado: (2023)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
por: Prasanna, Thiru, et al.
Publicado: (2017)

Bilateral symmetrical corneal melting following intravesical Bacille Calmette-Guerin therapy for bladder carcinoma
por: Chakraborty, Chandana, et al.
Publicado: (2012)

Bladder Contracture – A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy
por: Garcia, Cindy, et al.
Publicado: (2015)

Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
por: Sampaio, Paula Cíntia Machado, et al.
Publicado: (2017)

Renal Tuberculosis Following Intravesical Bacillus Calmette–Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer
por: Bajramovic, Senad, et al.
Publicado: (2020)

Uncommon adverse events of intravesical Bacillus Calmette-Guérin treatment: A report of three cases
por: Topuz, Bahadır, et al.
Publicado: (2021)

A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer
por: Gupta, Sachin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jb5r9dafjfcjrs1gqo7av7no7m